MYCOPLASMA GENITALIUM A PRACTICAL GUIDE

Similar documents
Management of NGU (Non-gonococcal urethritis)

STIs: Practical Aspects of Management

Clinical Guidelines Update (aka Know Your NAATs)

Answers to those burning questions -

Mycoplasma Genitalium: Get to Know the Hidden STI

Mycoplasma genitalium: An Important Consideration in Male Urethritis DR. ALEXANDRA CARLE

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch

Testing, Treating and Managing STIs Dr Jean Irvine

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

CLINICAL MANAGEMENT OF STDS

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council

STI control. Dr. Jane Morgan Hamilton Sexual Health Clinic

Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS

Cost-effectiveness of abandoning microscopy of urethral smears for asymptomatic nonchlamydial non-gonococcal urethritis in men in the UK

Non-gonococcal urethritis. Looking after your sexual health

Gynaecology. Pelvic inflammatory disesase

STIs- REVISION. Prof A A Hoosen

Responsibilities in a sexual relationship - Contact tracing

Update on Sexually Transmitted Infections among Persons Living with HIV

Extragenital Gonorrhea and Chlamydia among MSM

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

A healthy respect for Sexual Health. Dee Archbold CNC Princess Alexandra Sexual Health

WHAT DO U KNOW ABOUT STIS?

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

STDs and Hepatitis C

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

What's the problem? - click where appropriate.

STI Diagnostics Redesign. HVS and Chlamydia Resource Pack

Nothing to disclose.

ONLINE SUPPLEMENTARY MATERIALS: FILE 1

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

Sexually transmitted infections (in women)

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

TRICHOMONAS VAGINALIS

Challenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A

Welcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.

25/02/2016. New onset low abdominal pain in women of reproductive age. New onset low abdominal pain: why it matters?

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None

STI Indicators by STI

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV.

Screening & Treating Chlamydia in Primary Care. Wednesday, September 21, 2016

Sexual health screening

Podcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43

Sexually Transmitted Diseases

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs

Clinical Cases from the STD Clinical Consultation Network

GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016

MG and PID. Dr Jeannie Oliphant Dr Sunita Azariah Auckland Sexual Health Service

LET S TALK about Sticking with your treatment plan

Sex Talk for Self-Advocates #3 Safe Sex Practices - Sexually Transmitted Infections (STIs)

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

Learning Objectives. STI Update. Case 1 6/1/2016

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION VI. Friday, MARCH 20, 2015 STUDENT COPY

Clinical Education Initiative URETHRITIS. Elizabeth Asiago-Reddy, MD

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

STI 2016: Where We Need to Go

Dermatologist Venereologist MD, PhD

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers

Sexually Transmi/ed Diseases

GP Perspective about prescribing PEP & PrEP

Clinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP

SEXUALLY TRANSMITTED INFECTIONS (STIS)

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016

APPENDIX A SERVICE SPECIFICATION

5/1/2017. Sexually Transmitted Diseases Burning Questions

Partner Counseling and Referral Services

Sexually Transmitted Diseases. Chlamydial. infection. Questions and Answers

Sexual Health reproduction in reference to treatment as/for prevention

University Health Services at CMU STI Awareness Month specials for students:

That Other Chlamydia: Lymphogranulom a Venereum (LGV)

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP?

Services for GLBTQ Youth

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

Control and Prevention of Sexually Transmitted Infections; Chlamydia trachomatis. Dr Nathalie Broutet Department of Reproductive Health and Research

Love Bugs and Drugs Managing Sexually Transmitted Infections in Teens. Renée R. Jenkins, M.D., F.A.A.P. Howard University College of Medicine

People with genital herpes require enough information and medication (when indicated) to self-manage their condition.

STIs and BBVs. The facts

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL

TDL Sexual Health 2019

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH

Professor Jonathan Ross

PARTICIPANT DIARY TREATMENT ALLOCATION: LACTIC ACID GEL

PARTICIPANT DIARY TREATMENT ALLOCATION: ORAL METRONIDAZOLE TABLETS

Clinical Practice Objectives

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL

Update on Sexual Health: Screening, Diagnosing and Treating STIs

LEARNING NATIONAL CURRICULUM. Herpes virus. This section aims to teach students how sexual activity can lead to the spread of microbes and disease.

PART 3: HOW TO PROVIDE STI TEST RESULTS

Ask at Least Annually. Ask Older Adults. Have you been sexually active in the last year? Have you ever been sexually active?

Transcription:

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1

ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE ANTIBIOTICS OFTEN MULTIPLE PRACTITIONERS ANTIBIOTIC RESISTANCE ACCESS TO TREATMENT TIMEFRAMES 2

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE WHO TO TEST TESTS FROM WHERE WITH WHAT MANAGEMENT OF POSITIVE TESTS TREATMENT SEXUAL CONTACTS TEST OF CURE 3

BOTTOM LINE DOXYCYCLINE FIRST LINE FOR NON GONOCOCCAL URETHRITIS TALK TO LABORATORY PREVENTION REINFECTION - CONDOMS CAN BE FRUSTRATING ASK ADVICE MYCOPLASMA IS ONE OF THE CAUSES OF URETHRITIS 4

TESTING WHO SYMPTOMATIC RECURRENT OR PERSISTENT URETHRITIS PID NOT RESPONDED TO TREATMENT CERVICITIS NOT RESPONDED TO TREATMENT CONTACTS LAST 3/12 HOW URETHRAL FVU CERVICAL RECTAL BE VERY CLEAR ON LAB FORM WHAT YOU ARE REQUESTING 5 TEST OF CURE 3/52

6

MANAGEMENT OF POSITIVE TESTS TREATMENT 500MG OF AZITHROMYCIN DAY 1, THEN 250MG DAILY DAYS 2-5 IF ALREADY HAD AZITHROMYCIN MOXIFLOXACIN 400MG DAILY FOR 7 DAYS - SPECIAL AUTHORITY MACROLIDE RESISTANT MOXIFLOXACIN 400MG DAILY FOR 7 DAYS SPECIAL AUTHORITY APPLY FOR WAIVER 7

RE SPECIAL AUTHORITY APPLICATIONS. IF YOU HAVE ANY QUERIES REGARDING THE PROCESSING OF PAPER BASED OR DECLINED SPECIAL AUTHORITY APPLICATIONS, PLEASE CONTACT SECTOR SERVICES ON 0800 243 666. CALL TO DISCUSS FAST-TRACKING APPLICATION AND WAIVERS 8

MANAGEMENT OF POSITIVE TESTS DISCUSS CONDITION GIVE WRITTEN INFORMATION CONTACT TRACING 3/12 AVOID REINFECTION NO SEX UNTIL 1/52 POST TREATMENT THEN CONDOMS UNTIL NEG TOC 1/52 FOLLOW UP VISIT/CALL TOC 3/52 9

10

FOLLOW UP RESULTS 1/52 FOLLOW UP VISIT/CALL SYMPTOM RESOLUTION ADHERENCE TO TREATMENT CONTACT TRACING RISK REINFECTION REMIND RE NO SEX UNTIL 1/52 AFTER COMPLETION TREATMENT THEN CONDOMS UNTIL NEGATIVE TOC BOOK TOC IF NOT ALREADY DONE SO ADD TO RECALL SYSTEM TEST OF CURE 3/52 IF POSITIVE TREATMENT DEPENDS ON: PREVIOUS TREATMENTS? REINFECTION? RESISTANT 11

MANAGEMENT SEXUAL CONTACTS BE CLEAR CONTACT OF M. GENITALIUM WRITE IT / TEXT IT / PRINT IT!!!!!!! CONTACTS PENILE / VAGINAL / ANO-RECTAL 3/12 TEST? TREAT BEFORE RESULTS SYMPTOMATIC AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 ASYMPTOMATIC DEPENDS ON HISTORY EXPOSURE NO SEX WITH SEXUAL CONTACTS FROM THE LAST 3 MONTHS UNTIL 7 DAYS AFTER BOTH THE PATIENT AND ONGOING SEXUAL CONTACTS HAVE COMPLETED THEIR TREATMENT, THEN CONDOMS UNTIL BOTH NEGATIVE TOC 12

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 1 FROM ONSET SYMPTOMS 1/52 Urethral irritation Penile discharge, clear WHAT DO YOU DO? Background 2/7 ago penetrative penile anal no condom, partner, regular sexual contact 3/52 ago receptive penile anal, condom, regular sexual contact 3/12 ago, penetrative penile vaginal, condom STI screening 12/12 ago NAD Nil else of note O/E NAD except clear colourless fluid urethral meatus 13

TREATMENT URETHRITIS DOXYCYCLINE 100MG BD 1/52 DISCUSS DIAGNOSIS URETHRITIS TEST CHLAMYDIA AND GONORRHOEA NAAT PO PA FVU SEROLOGY HIV, SYPHILIS EXPLANATION OF WHAT TESTING FOR INCLUDING WINDOW PERIODS ETC DISCUSS + OFFER CONDOM NO SEX UNTIL 7/7 AFTER COMPLETED TREATMENT CHECK CONTACT DETAILS FOR TEST RESULTS DISCUSS CONTACT TRACING LAST 2/12 FOLLOW UP 1/52 14

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 3 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS DOXYCYCLINE 100MG BD 1/52 WHAT DO YOU DO? 2/52 TESTS NAD CALLED TO GIVE RESULTS, NO ANSWER, DIDN T REPLY TO MESSAGES 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC HAS FOLLOWED YOUR ADVICE EXAM NAD 15

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 3 FROM ONSET SYMPTOMS Persistent urethritis o Discuss possible causes including M.genitalium o Testing M. genitalium FVU, rectal swab, timeframe results other testing as guided by history and exam findings o Treatment o Azithromycin 500mg day 1, then 250mg days 2-5 + Metronidazole 400mg bd 1/52 o If already treated with Azithromycin 1g, Doxycycline 100mg bd 1/52 o Re reinfection + transmission no sex until 1/52 post completion treatment 16 CONDOMS o Contact tracing 3/12

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM WHAT DO YOU DO? 18

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM PLAN DISCUSS + GIVE WRITTEN INFO CHECK SYMPTOMS CONTACT TRACING ENSURE THEY KNOW ITS M.GENITALIUM DISCUSSION TRANSMISSION REINFECTION CONDOMS IF ASYMPTOMATIC TOC 3/52 19

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 8 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM ASYMPTOMATIC 6/52 TEST OF CURE 8/52 NEGATIVE M GENITALIUM 20

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM IF STILL HAS SYMPTOMS WHAT DO YOU DO? 21

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 5 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM IF STILL HAS SYMPTOMS MOXIFLOXACIN 400MG OD 7/7 WRITTEN INFO DISCUSSION TRANSMISSION REINFECTION CONTACT TRACING ENSURE THEY KNOW ITS M.GENITALIUM CONDOMS 1/52 FOLLOW UP TOC 3/52 22

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 NEGATIVE M GENITALIUM 23

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 POSITIVE M GENITALIUM SEEK ADVICE! 24

32 YEAR OLD URETHRAL IRRITATION AND PENILE DISCHARGE WEEK 10 FROM ONSET SYMPTOMS TIME FROM ONSET SYMPTOMS 1/52 1 ST CLINIC APPOINTMENT HX, EXAM, TESTS, DOXYCYCLINE 100MG BD 1/52 3/52 CALLED CLINIC, STILL HAS SYMPTOMS, SEEN AT CLINIC STILL SYMPTOMATIC, HAS FOLLOWED YOUR ADVICE, EXAM NAD AZITHROMYCIN 500MG DAY 1, THEN 250MG DAYS 2-5 5/52 POSITIVE M. GENITALIUM SYMPTOMATIC, MOXIFLOXACIN 400MG OD 7/7 8/52 TEST OF CURE 10/52 NEGATIVE M GENITALIUM BUT WHAT ABOUT THE CONTACTS?! 1. 2/7 AGO PENETRATIVE PENILE ANAL NO CONDOM, PARTNER, REGULAR SEXUAL CONTACT 2. 3/52 AGO RECEPTIVE PENILE ANAL, CONDOM, REGULAR SEXUAL CONTACT 3. 3/12 AGO, PENETRATIVE PENILE VAGINAL, CONDOM 26

INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSON HAS HAD DOXYCYCLINE, NO BETTER, NOW HAVING AZITHROMYCIN 500MG D1, 250MG DAY 2-5 THEY HAVE REGULAR PENILE ANAL SEXUAL CONTACT CONDOMLESS AWARE MG TESTING, NO RESULT YET SYMPTOMATIC URETHRITIS BARRIERS TO CONDOM USE CLEAR URETHRAL DISCHARGE MEATUS WHAT DO YOU DO? 27

INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSONS PARTNER WEEK 4 SINCE INDEX PERSONS SYMPTOMS STARTED INDEX PERSON HAS HAD DOXYCYCLINE, NO BETTER, NOW HAVING AZITHROMYCIN 500MG D1, 250MG DAY 2-5 THEY HAVE REGULAR PENILE ANAL SEXUAL CONTACT CONDOMLESS AWARE MG TESTING, NO RESULT YET SYMPTOMATIC URETHRITIS BARRIERS TO CONDOM USE CLEAR URETHRAL DISCHARGE MEATUS PLAN TEST FVU + RECTAL SWAB EPIDEMIOLOGICAL TREATMENT WITH AZITHROMYCIN 500MG OD, 250MG OD DAYS 2-5 ALSO REITERATE NO SEX RESISTANT BUGS CONDOMS (DONT FORGET CONSIDERING OTHER CAUSES URETHRITIS, STI TESTING, FOLLOW UP RESULTS ETC) \ 28

ASYMPTOMATIC CONTACT 7 WEEKS FROM START INDEX PERSONS SYMPTOMS ASYMPTOMATIC CONTACT WHAT WOULD YOU DO? REGULAR ANAL RECEPTIVE AND INSERTIVE, CONDOMS NOT HAD SEX WITH INDEX CASE 7/52 TEXT SAYING TREATED STI BEEN TESTED AND NAD, ANOTHER SAYING?MG 29

ASYMPTOMATIC CONTACT 7 WEEKS FROM START INDEX PERSONS SYMPTOMS ASYMPTOMATIC CONTACT REGULAR ANAL RECEPTIVE AND INSERTIVE NOT HAD SEX WITH INDEX CASE 7/52 TEXT SAYING TREATED STI BEEN TESTED AND NAD, ANOTHER SAYING?MG AZITHROMYCIN 5/7 PLAN - TEST AND WAIT - IF SYMPTOMATIC - AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 - ALSO USUAL CONSULTATION HAVE WITH CONTACTS, STI TESTING ETC 30

ASYMPTOMATIC CONTACT 10 WEEKS FROM START INDEX PERSONS SYMPTOMS 3 /12 AGO WHAT DO YOU DO? RECEPTIVE PENILE VAGINAL CONDOM NO SYMPTOMS EXAMINATION NAD 31

ASYMPTOMATIC CONTACT 10 WEEKS FROM START INDEX PERSONS SYMPTOMS 3 1/12 AGO RECEPTIVE PENILE VAGINAL X1 CONDOM NO SYMPTOMS PLAN - TEST AND WAIT - IF SYMPTOMATIC / INDICATIVE FINDINGS -? ANY MORE INFORMATION AVAILABLE RE TEST RESULTS AND TREATMENTS? - AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 - ALSO USUAL CONSULTATION HAVE WITH CONTACTS, STI TESTING ETC 32

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE USE DOXYCYCLINE FOR PEOPLE WHO PRESENT WITH URETHRITIS THAT YOU DON T THINK IS CAUSED BY GONORRHOEA M.GENITALIUM TREATED WITH AZITHROMYCIN 500MG DAY 1, 250MG DAYS 2-5 MOXIFLOXACIN 400MG OD 7/7 SPEAK TO SPECIAL AUTHORITY TEAM CAN FASTTRACK AND DO WAIVERS FOR MACROLIDE RESISTANT TESTING KNOW HOW TO ORDER SPEAK TO YOUR LAB WHAT TO USE BE CLEAR ON THE LAB FORM BE MINDFUL OF THE TIMEFRAMES AND POTENTIAL DELAYS! PRESENTATIONS, TESTING, RESULTS, APPROVAL FOR MEDS, GETTING THE MEDS, TAKING THE MEDS.TESTS OF CURE AND CONTACT TRACING WITH RISKS REINFECTION AS WELL AS RESISTANCE WRITE MYCOPLASMA GENITALIUM DOWN / TEXT / PRINT INFO FOR PEOPLE SO CONTACTS CAN BE TESTED AND TREATED APPROPRIATELY ASK FOR ADVICE 33

REFERENCES NZ SHS WEBSITE EUROPEAN GUIDELINES MG BASHH URETHRITIS SPECIAL AUTHORITY FORMS 34